8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Cancer & Tumors1,064 citations

Ye W, Wang F, Zhang W, Fang N, Zhao W, Wang J

Bioeffects Seen

Authors not listed · 2016

Share:

New lung cancer genes identified could help explain how environmental exposures contribute to cancer development.

Plain English Summary

Summary written for general audiences

Researchers analyzed genetic sequences from 1,144 lung cancer tumors to identify new cancer-driving genes and mutations. They found that lung adenocarcinoma and squamous cell carcinoma have distinct genetic profiles, with several newly identified genes that contribute to cancer development. The study suggests both cancer types could benefit from immunotherapy treatments.

Why This Matters

While this study focuses on lung cancer genetics rather than EMF exposure, it provides crucial context for understanding how environmental factors might contribute to the cancer-driving mutations they identified. The reality is that we're still learning how external exposures, including electromagnetic fields, might influence the genetic pathways highlighted in this research. What makes this particularly relevant is that many of the newly identified cancer genes (like PPP3CA and DOT1L) are involved in cellular stress responses and DNA repair mechanisms that could potentially be disrupted by chronic EMF exposure. The study's finding that 47-53% of lung cancers had significant immune system targets also raises questions about whether EMF exposure might affect the immune surveillance that normally prevents cancer development.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2016). Ye W, Wang F, Zhang W, Fang N, Zhao W, Wang J.
Show BibTeX
@article{ye_w_wang_f_zhang_w_fang_n_zhao_w_wang_j_ce3107,
  author = {Unknown},
  title = {Ye W, Wang F, Zhang W, Fang N, Zhao W, Wang J},
  year = {2016},
  doi = {10.1038/ng.3564},
  
}

Quick Questions About This Study

The study identified several previously unknown cancer-driving genes including PPP3CA, DOT1L, and FTSJD1 in adenocarcinoma, RASA1 in squamous cell carcinoma, and KLF5, EP300, and CREBBP in both cancer types.
Researchers examined 1,144 tumor samples total: 660 lung adenocarcinoma cases and 484 lung squamous cell carcinoma cases, comparing each tumor's genetics to normal tissue from the same patient.
No, the study found lung squamous cell carcinomas were more genetically similar to other squamous cancers than to lung adenocarcinomas, suggesting these lung cancer types develop through different biological pathways.
The study found 47% of adenocarcinomas and 53% of squamous cell carcinomas had at least five predicted neoepitopes, which are protein fragments that could potentially be targeted by immunotherapy treatments.
Some lung adenocarcinomas without typical receptor tyrosine kinase-Ras-Raf pathway changes instead had mutations in alternative genes like SOS1, VAV1, RASA1, and ARHGAP35, suggesting different routes to cancer development.